Outlook Therapeutics, Inc. (OTLK) Insider Trading
Sector: Biotechnology · Market Cap: $126M · 0 insider purchases in the last 7 days
No open market insider purchases at Outlook Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track OTLK on your watchlist.
Start for FreeAbout Outlook Therapeutics, Inc. Insider Trading
1 insider at Outlook Therapeutics, Inc. (OTLK) has purchased stock in the past 90 days, totaling $2.5M across 1 transaction (2,525,252 shares).
The most recent purchase was by Director Sukhtian Ghiath M. on August 12, 2026 — a $2.5M buy of 2,525,252 shares at $0.99, bringing their total holdings to 24,617,320 shares.
This level of insider buying appears elevated compared to OTLK's typical activity — there were 1 purchase in the prior nine months.
OTLK is in the Biotechnology sector within the Biotechnology industry with a market cap of $126M.
Track OTLK insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.